Review reveals high rates of asymptomatic tuberculosis among confirmed cases, highlighting the need for symptom-agnostic screening to curb transmission.
Key Points
To review the prevalence, biological characteristics, diagnostic hurdles, and treatment considerations associated with asymptomatic tuberculosis.
Synthesized findings from national tuberculosis prevalence surveys and World Health Organization screening guidelines.
Assessed biological features of asymptomatic disease, including bacillary load and sputum production constraints, alongside treatment adherence challenges.
National prevalence surveys show that nearly half of all bacteriologically confirmed tuberculosis cases present without self-reported symptoms at initial screening.
Asymptomatic infection correlates with lower bacillary burden and limited sputum production, reducing the clinical sensitivity of standard sputum-based diagnostic assays.
Absence of overt symptoms compromises treatment initiation and completion rates because individuals experience no immediate symptomatic relief from taking medications.